论文部分内容阅读
用~(131)I治疗甲亢在我国各大医院核医学科已成为很普遍的治疗项目.在用~(131)I治疗甲亢的过程中大家曾担心是否会引起早期严重并发症——甲状腺危象的发生.观察服用~(131)I后短期内患者血清中甲状腺激素水平变化对于探讨这问题以及指导配合治疗在临床上均有重要的意义.资料和方法自1981年以来我们曾陆续临床观察54例(男性19例,女性37例),年龄27～59岁,均为弥漫性甲状腺肿(Graver’s病).其中合并心房纤颤者5例、周期性麻痹者8例、甲亢次全手术后复发者4例、合并甲癌者2例.患者治疗前都有典型的甲亢症状
Treatment of hyperthyroidism with ~ (131) I has become a very common treatment project in the nuclear medicine department of major hospitals in China. In the treatment of hyperthyroidism with ~ (131) I have been worried whether it will cause early serious complications - thyroid risk The occurrence of thyroid hormone in patients with ~ (131) I short-term observation of the changes in serum thyroid hormone levels for the exploration of this issue and guide the combination therapy in clinical significance are important.Material and methods Since 1981, we have been one after another clinical observation 54 cases (19 males and 37 females) aged 27-59 years were Graver’s disease, including 5 cases with atrial fibrillation, 8 cases with periodic paralysis, sub-total hyperthyroidism 4 cases of recurrence, 2 cases of combined carcinoma of the neck.The patients had typical symptoms of hyperthyroidism before treatment